Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Cipla Limited, is a listed public company incorporated on 17 August, 1935. It is classified as a public limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 175.00 cr and the total paid-up capital is INR 161.51 cr.
Cipla Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 12.66% over the previous year. At the same time, it's book networth has increased by 9.44%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Samina Hamied
Shareholder
|
00027923 | 9 years |
Director | Yusuf Khwaja Hamied
Shareholder
|
00029049 | 52 years |
Director | Mustafa Khwaja Hamied
Shareholder
|
00029084 | 47 years |
Director | Prathivadibhayankara Rajagopalan Ramesh | 01915274 | 3 years |
Managing Director | Umang Vohra
Shareholder
|
02296740 | 8 years |
Director | Sharmila Nitin Paranjpe | 02328770 | 0 years |
Director | Punita Lal | 03412604 | 10 years |
Director | Robert Stewart | 03515778 | 3 years |
Director | Adil Zainulbhai | 06646490 | 10 years |
CS | Rajendra Kumar Chopra
Shareholder
|
<HIDDEN> | 8 years |
Director | Abhijit Jagdish Joshi | 07115673 | 0 years |
CFO | Ashish Adukia | <HIDDEN> | 2 years |
Director | Mandar Purushottam Vaidya | 09690327 | 2 years |
Director | Balram Bhargava | 10479707 | 1 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
HAMSONS LABORATORIES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
40.0 L | 1 | Maharashtra |
TWIST PHARMA PRIVATE LIMITED |
Strike Off
|
25.0 L | 1 | Maharashtra |
CIPLA HEALTH LIMITED |
Active
|
2.3 Cr | 2 | Maharashtra |
GLOBUS HEALTHCARE LIMITED |
Strike Off
|
5.0 L | 1 | Maharashtra |
M K HAMIED FOUNDATION |
Active
|
1.0 L | 1 | Maharashtra |
HOUSING DEVELOPMENT FINANCE CORPORATION LIMITED |
Amalgamated
|
370.3 Cr | 1 | Maharashtra |
THE CLEARING CORPORATION OF INDIA LIMITED |
Active
|
50.0 Cr | 1 | Maharashtra |
FORUM FOR INDIAN ACCOUNTING RESEARCH |
Active
|
0.0 | 1 | Telangana |
ITC HOTELS LIMITED |
Active
|
83.0 Cr | 1 | West Bengal |
AIX CONNECT PRIVATE LIMITED |
Amalgamated
|
4,195.0 Cr | 1 | Haryana |
LARSEN AND TOUBRO LIMITED |
Active
|
274.9 Cr | 1 | Maharashtra |
CROMPTON GREAVES CONSUMER ELECTRICALS LIMITED |
Active
|
128.7 Cr | 1 | Maharashtra |
TEJAS NETWORKS LIMITED |
Active
|
171.3 Cr | 1 | Karnataka |
AIR INDIA LIMITED |
Active
|
35,360.2 Cr | 1 | Haryana |
NSE INVESTMENTS LIMITED |
Active
|
826.0 Cr | 1 | Maharashtra |
AIR INDIA EXPRESS LIMITED |
Active
|
1,017.1 Cr | 1 | Haryana |
NESTLE INDIA LIMITED |
Active
|
96.4 Cr | 1 | Delhi |
I-VEN PHARMA CAPITAL LIMITED |
Under Liquidation
|
8.9 L | 1 | Karnataka |
STEMPEUTICS RESEARCH PRIVATE LIMITED |
Active
|
59.7 Cr | 1 | Karnataka |
DOOR STEP SCHOOL FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
OPEN NETWORK FOR DIGITAL COMMERCE |
Active
|
754.0 Cr | 1 | Delhi |
C3 MEDICARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
SAMSHIKSHA FOUNDATION |
Active
|
0.0 | 1 | Delhi |
UNNATI EMPLOYMENT NETWORK |
Active
|
2.5 Cr | 1 | Delhi |
NETWORK18 MEDIA & INVESTMENTS LIMITED |
Active
|
523.5 Cr | 1 | Maharashtra |
RELIANCE RETAIL VENTURES LIMITED |
Active
|
7,011.2 Cr | 1 | Maharashtra |
TV18 BROADCAST LIMITED |
Active
|
342.9 Cr | 1 | Maharashtra |
PIRAMAL FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
RELIANCE RETAIL LIMITED |
Active
|
8,987.0 Cr | 1 | Maharashtra |
VIACOM 18 MEDIA PRIVATE LIMITED |
Active
|
428.3 Cr | 1 | Maharashtra |
STEP UP CHARITABLE FOUNDATION |
Active
|
80,000.0 | 1 | Maharashtra |
NAVIN FLUORINE INTERNATIONAL LIMITED |
Active
|
9.9 Cr | 1 | Maharashtra |
BHARTI TELE COM LTD |
Not available for efiling
|
0.0 | 1 | Delhi |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
The Cipla Empowerment Trust | South Africa | - | - |
Cipla Health Employees Stock Option Trust | - | - | - |
Aspergen Inc | United States | - | - |
Mirren (Pty) Limited | South Africa | - | - |
Medpro Pharmaceutica (Pty) Limited | South Africa | - | - |
Cipla Select (Pty) Limited | South Africa | - | - |
Cipla Medpro Botswana (Pty) Limited | Botswana | - | - |
Cipla-Medpro Distribution Centre (Pty) Limited | South Africa | - | - |
Cipla-Medpro (Pty) Limited | South Africa | - | - |
Cipla Medpro Manufacturing (Pty) Limited | South Africa | - | - |
Cipla Dibcare (Pty) Limited | South Africa | - | - |
Cipla Therapeutics Inc | United States | - | - |
Cipla Kenya Limited | Kenya | - | - |
Madison Pharmaceuticals Inc. | United States | - | - |
Cipla Technologies LLC | United States | - | - |
Exelan Pharmaceuticals Inc. | United States | - | - |
InvaGen Pharmaceuticals Inc. | United States | - | - |
Cipla USA Inc. | United States | - | - |
Cipla (China) Pharmaceutical Co., Limited | China | - | - |
Cipla (Jiangsu) Pharmaceutical Co., Limited | China | - | - |
Cipla Colombia SAS | Colombia | - | - |
Cipla Philippines Inc. | Philippines | - | - |
Cipla EU Limited | United Kingdom | - | - |
Cipla Brasil Importadora E Distribuidora De Medicamentos Ltda. | Brazil | - | - |
Cipla Australia Pty Limited | Australia | - | - |
Cipla Maroc SA | Morocco | - | - |
Breathe Free Lanka (Private) Limited | Sri Lanka | - | - |
Cipla Malaysia Sdn. Bhd. | Malaysia | - | - |
Cipla Gulf FZ – LLC | United Arab Emirates | - | - |
Cipla Middle East Pharmaceuticals FZ-LLC | United Arab Emirates | - | - |
Cipla Medica Pharmaceutical and Chemical Industries Limited | Yemen | - | - |
Saba Investment Limited | United Arab Emirates | - | - |
Cipla Holding B.V. | Netherlands | - | - |
Cipla Europe NV | Belgium | - | - |
Cipla Algerie | Algeria | - | - |
Meditab Holdings Limited | Mauritius | - | - |
Cipla Quality Chemical Industries Limited | Uganda | - | - |
Cipla Medpro South Africa (Pty) Limited | South Africa | - | - |
CIPLA DIGITAL HEALTH LIMITED | Maharashtra | 2022 | ₹ 30.0 Cr |
CIPLA PHARMACEUTICALS LIMITED | Maharashtra | 2019 | ₹ 72.0 Cr |
CIPLA PHARMA AND LIFE SCIENCES LIMITED | Maharashtra | 2008 | ₹ 258.7 Cr |
CIPLA HEALTH LIMITED | Maharashtra | 2015 | ₹ 2.3 Cr |
SITEC LABS LIMITED | Maharashtra | 2000 | ₹ 1.6 L |
GOLDENCROSS PHARMA LIMITED | Maharashtra | 2000 | ₹ 4.6 L |
MEDISPRAY LABORATORIES PRIVATE LIMITED | Goa | 1992 | ₹ 5.1 L |
MEDITAB SPECIALITIES LIMITED | Maharashtra | 1996 | ₹ 71.2 L |
JAY PRECISION PHARMACEUTICALS PRIVATE LIMITED | Maharashtra | 2012 | ₹ 4.0 Cr |
The Cipl a Empowerment Trust | South Africa | - | - |
The incorporation date of CIPLA LIMITED is 17 August, 1935
The authorized share capital of CIPLA LIMITED is INR ₹ 175.0 Cr.
The paid-up capital of CIPLA LIMITED is INR ₹ 161.5 Cr.
The registered address of CIPLA LIMITED is Cipla House, Peninsula Business Park Ganpatrao Kadam Marg, Lower Parel NA Mumbai Mumbai City Maharashtra - 400013
The CIN number of CIPLA LIMITED is L24239MH1935PLC002380.